References
- Shaib YH, Davila JA, McGlynn K, et al. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol. 2004;40(3):472–477.
- Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis. 2004;24(2):115–125.
- Bridgewater J, Galle PR, Khan SA, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol. 2014;60(6):1268–1289.
- Si A, Li J, Xiang H, et al. Actual over 10-year survival after liver resection for patients with intrahepatic cholangiocarcinoma. Oncotarget. 2017; 8(27):44521–44532.
- Wei F, Chen L, Cai L, et al. Can laparoscopic liver resection provide a favorable option for patients with large or multiple intrahepatic cholangiocarcinomas? Surg Endosc. 2017;31(9):3646–3610.
- Criscitiello C, Esposito A, Trapani D, et al. Prognostic and predictive value of tumor infiltrating lymphocytes in early breast cancer. Cancer Treat Rev. 2016;50:205–207.
- Gasparri ML, Attar R, Palaia I, et al. Tumor infiltrating lymphocytes in ovarian cancer. Asian Pac J Cancer Prev. 2015;16(9):3635–3638.
- Geng Y, Shao Y, He W, et al. Prognos- tic role of Tumor-Infiltrating lymphocytes in lung cancer: a meta-analysis. Cell Physiol Biochem. 2015;37(4):1560–1571.
- Rozek LS, Schmit SL, Greenson JK, et al. Tumor-Infiltrating lymphocytes, Crohn’s-Like lym- phoid reaction, and survival from colorectal cancer. J Natl Cancer Inst. 2016;108(8):djw027.
- Salgado R, Denkert C, Demaria S, et al. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. Ann Oncol. 2015;26(2):259–271.
- Lohneis P, Sinn M, Bischoff S, et al. Cytotoxic tumour-infiltrating T lymphocytes influence outcome in resected pancreatic ductal adenocarcinoma. Eur J Cancer. 2017;83:290–301.
- Fukunaga A, Miyamoto M, Cho Y, et al. CD8+ tumor-infiltrating lymphocytes together with CD4+ tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma. Pancreas. 2004;28(1):e26–e31.
- Lianyuan T, Dianrong X, Chunhui Y, et al. The predictive value and role of stromal tumor-infiltrating lymphocytes in pancreatic ductal adenocarcinoma (PDAC). Cancer Biol Ther. 2018; 19(4):296–210.
- Apte MV, Xu Z, Pothula S, et al. Pancreatic cancer: the microenvironment needs attention too!. Pancreatology. 2015;15(4 Suppl):S32–S38.
- Carr RM, Fernandez-Zapico ME. Pancreatic cancer microenvironment, to target or not to target? EMBO Mol Med. 2016;8(2):80–82.
- Sun XJ, Jiang TH, Zhang XP, et al. Role of the tumor microenvironment in pancreatic adenocarcinoma. Front Biosci (Landmark Ed)). 2016;21(1):31–41.
- Edge SB, Compton CC. The american joint committee on cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17(6):1471–1474.
- Lei Y, Xie Y, Tan YS, et al. Telltale tumor infiltrating lymphocytes (TIL) in oral, head & neck cancer. Oral Oncol. 2016;61:159–165.
- Ogiya R, Niikura N, Kumaki N, et al. Comparison of tumor-infiltrating lymphocytes between primary and metastatic tumors in breast cancer patients. Cancer Sci. 2016;107(12):1730–1735.
- Dodson RM, Weiss MJ, Cosgrove D, et al. Pawlik TM, Intrahepatic cholangiocarcinoma: management options and emerging therapies. J Am Coll Surg. 2013; 217(4):736–750.
- Shah UA, Nandikolla AG, Rajdev L. Immunotherapeutic approaches to biliary cancer. Curr Treat Options Oncol. 2017; 18(7):44.
- Zhanfeng X, Xiaoyu W, Nan Z, et al. Prognosis after resection for hepatitis B virus-associated intrahepatic cholangiocarcinoma. World J Gastroenterol. 2015;21(3):935–943.
- Spolverato G, Bagante F, Weiss M, et al. Comparative performances of the 7th and the 8th editions of the American Joint Committee on Cancer Staging Systems for intrahepatic cholangiocarcinoma. J Surg Oncol. 2017;115(6):696–703.
- Kang SH, Hwang S, Lee YJ, et al. Prognostic comparison of the 7th and 8th editions of the American Joint Committee on Cancer Staging System for intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Sci. 2018;25(4):240–248.